Company intelligence / Profile preview
Mundipharma Research
Limburg an der Lahn, Hesse, Germanymundipharma.com ↗
- Ownership
- Private
- Employees
- ~200
- Development stage
- Other
01
Overview
Mundipharma Research has a strong history in developing analgesics and respiratory treatments, notably Targin and Flutiform. Currently, the company focuses on advancing its pain pipeline (including Sigma-1 antagonists) and commercializing biosimilars in oncology and inflammatory diseases.
- Therapeutic areas
- OncologyPulmonologyNeurologyGastroenterology
- Modalities
- Small moleculeMonoclonal antibodyPeptides
- Industry
- Pharma
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
CelltrionShionogiEsteve Pharmaceuticals
Beyond the preview
Go deeper on Mundipharma Research.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mundipharma Research.